title: [Comparative study of ofloxacin+amoxicillin-clavulanic acid versus doxycycline+amoxicillin-clavulanic acid combination in the treatment of pelvic Chlamydia trachomatis infections].
abstract: OBJECTIVE
  To evaluate the efficacy and safety of ofloxacin+coamoxiclav versus doxycycline-coamoxiclav in the treatment of chlamydial pelvic infections.
  
  
  METHODS
  An open, comparative, randomised, monocentric study.
  
  
  METHODS
  A hundred and eighteen patients (85 endometritis and 33 salpingitis) were included. Clinical, laparoscopic and bacteriological assessments were performed before treatment. 30.4% of salpingitis were considered as severe (COGIT score > 6). 25.4% of acute pelvic infections were only caused by Chlamydia trachomatis.
  
  
  METHODS
  A hundred and eighteen patients were treated orally with 3 week combination ofloxacin (200 mg b.i.d.) + coamoxiclav (1 g b.i.d.) (n = 60) or with a 6 week coamoxiclav (1 g b.i.d.) + doxycycline (100 mg b.i.d.) (n = 58).
  
  
  RESULTS
  Oral combination ofloxacin-coamoxiclav is as effective as oral combination doxycycline+coamoxyclav with respectively 96.7% versus 96.6% and 100% versus 98.4% satisfactory clinical et bacteriological results.
authors.affiliation: Clinique Universitaire de Gynécologie-Obstétrique, Maternité Régionale, Nancy.
authors.forename: P
authors.initials: P
authors.lastname: Judlin
authors.forename: A
authors.initials: A
authors.lastname: Koebele
authors.forename: A
authors.initials: A
authors.lastname: Zaccabri
authors.forename: E
authors.initials: E
authors.lastname: van Walleghen
authors.forename: A
authors.initials: A
authors.lastname: Pavis
authors.forename: Y
authors.initials: Y
authors.lastname: Badonnel
authors.forename: M
authors.initials: M
authors.lastname: Dailloux
authors.forename: P
authors.initials: P
authors.lastname: Landes
mesh_terms: D000293:Adolescent; D000328:Adult; D000658:Amoxicillin / Q000627:therapeutic use; D019980:Amoxicillin-Potassium Clavulanate Combination; D002690:Chlamydia Infections / Q000188:drug therapy* / Q000382:microbiology; D002692:Chlamydia trachomatis; D002969:Clavulanic Acids / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D004716:Endometritis / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D015242:Ofloxacin / Q000627:therapeutic use; D012488:Salpingitis / Q000188:drug therapy* / Q000382:microbiology; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D002969:Clavulanic Acids; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin; D015242:Ofloxacin; D004318:Doxycycline
vernacular_title: Etude comparative des associations ofloxacine+amoxicilline-acide clavulanique versus doxycycline+amoxicilline-acide clavulanique dans le traitement des infections génitales hautes à Chlamydia trachomatis.